BIOMAT Database Logo BIOMAT Database Logo

Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein. 2008

Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Laboratorio di Microbiologia e Virologia, Università "Vita-Salute" San Raffaele, DIBIT2, via Olgettina 60, 20132 Milano, Italia. mario.perotti@hsr.it

Identification of anti-hepatitis C virus (anti-HCV) human antibody clones with broad neutralizing activity is important for a better understanding of the interplay between the virus and host and for the design of an effective passive immunotherapy and an effective vaccine. We report the identification of a human monoclonal Fab (e137) able to bind the HCV E2 glycoprotein of all HCV genotypes but genotype 5. The results of antibody competition assays and testing the reactivity to alanine mutant E2 proteins confirmed that the e137 epitope includes residues (T416, W420, W529, G530, and D535) highly conserved across all HCV genotypes. Fab e137 neutralized HCV pseudoparticles bearing genotype 1a, 1b, and 4 E1-E2 proteins and to a lesser extent, genotype 2b. Fab e137 was also able to inhibit cell culture-grown HCV (genotype 2a). These data indicate that broadly cross-reacting and cross-neutralizing antibodies are generated during HCV infection.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D018604 Epitope Mapping Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry. Epitope Mappings,Mapping, Epitope,Mappings, Epitope
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.
December 2009, Journal of virology,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.
March 2008, The Journal of general virology,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.
September 2005, Journal of virology,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.
March 2006, Hepatology (Baltimore, Md.),
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
September 2016, Virus research,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection.
November 2018, Cell host & microbe,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
December 1994, AIDS research and human retroviruses,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.
December 2017, Antiviral research,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen.
June 2021, Applied microbiology and biotechnology,
Mario Perotti, and Nicasio Mancini, and Roberta A Diotti, and Alexander W Tarr, and Jonathan K Ball, and Ania Owsianka, and R Adair, and Arvind H Patel, and Massimo Clementi, and Roberto Burioni
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9.
April 2022, Chinese medical journal,
Copied contents to your clipboard!